Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis

[1] Inoue T(2015)Stereotactic body radiotherapy for stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis J Radiat Res 56 727-734

[2] Shiomi H(2012)Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema Br J Radiol 85 135-141

[3] Oh RJ(2012)Association of computed tomography-detected pulmonary interstitial changes with severe radiation pneumonitis for patients treated with thoracic radiotherapy J Radiat Res 53 110-116

[4] Kimura T(2003)Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study Radiother Oncol 67 275-283

[5] Togami T(2012)Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy Chest 141 858-866

[6] Takashima H(2013)Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity Int J Radiat Oncol Biol Phys 85 798-804

[7] Nishiyama Y(2014)Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer J Thorac Oncol 9 983-990

[8] Ohkawa M(1995)Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis Int J Radiat Oncol Biol Phys 33 455-460

[9] Nagata Y(1999)Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 323-329

[10] Sanuki N(2001)Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer Int J Radiat Oncol Biol Phys 51 650-659

[1] Inoue T(2015)Stereotactic body radiotherapy for stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis J Radiat Res 56 727-734

[2] Shiomi H(2012)Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema Br J Radiol 85 135-141

[3] Oh RJ(2012)Association of computed tomography-detected pulmonary interstitial changes with severe radiation pneumonitis for patients treated with thoracic radiotherapy J Radiat Res 53 110-116

[4] Kimura T(2003)Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study Radiother Oncol 67 275-283

[5] Togami T(2012)Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy Chest 141 858-866

[6] Takashima H(2013)Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity Int J Radiat Oncol Biol Phys 85 798-804

[7] Nishiyama Y(2014)Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer J Thorac Oncol 9 983-990

[8] Ohkawa M(1995)Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis Int J Radiat Oncol Biol Phys 33 455-460

[9] Nagata Y(1999)Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 323-329

[10] Sanuki N(2001)Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer Int J Radiat Oncol Biol Phys 51 650-659